Amdocs Limited Ordinary Shares (DOX)

FairStock Score: 70/100 — STEADY

Key Financials

Strengths

• Generates $598 million in annual free cash flow (8.8% yield on market cap)
• Solid return on equity of 16.5% above cost of capital
• Conservative balance sheet with debt-to-equity of just 0.27, providing financial flexibility
• Attractive 3.5% dividend yield providing steady income returns
• FairStock composite score of 70/100 places it in the top tier across value, quality, and momentum factors

AI Analysis

Amdocs Limited Ordinary Shares is a small-cap technology company valued at $6.8 billion. The business generates $4.6 billion in annual revenue with a 3.4% net margin and $598 million in free cash flow. From a quality standpoint, Amdocs shows healthy Altman Z-Score of 3.3 and adequate 16% ROE. On valuation, the stock is attractively valued at 12.5x earnings, with trades above its Graham Number with a negative 4% margin. Growth dynamics show revenue growing at 4.1% and profit growth of 4.3%. The 3.5% dividend yield adds an income component for patient holders. Our composite FairStock Score of 70/100 reflects above-average fundamentals overall. This combination of reasonable valuation, solid returns, and conservative leverage makes it worth a closer look for value-oriented portfolios.

Bull Case

The market underappreciates Amdocs's consistent 16% ROE at just 13x earnings—a re-rating toward sector peers could unlock 30-50% upside. With $598 million in annual free cash flow (8.8% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the technology space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer